Foundations Investment Advisors LLC Sells 43,691 Shares of UnitedHealth Group Incorporated $UNH

Foundations Investment Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 71.6% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 17,355 shares of the healthcare conglomerate’s stock after selling 43,691 shares during the quarter. Foundations Investment Advisors LLC’s holdings in UnitedHealth Group were worth $5,993,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in UNH. LFA Lugano Financial Advisors SA purchased a new stake in UnitedHealth Group during the second quarter valued at $25,000. Sagard Holdings Management Inc. bought a new position in shares of UnitedHealth Group in the 2nd quarter valued at about $29,000. Islay Capital Management LLC bought a new stake in UnitedHealth Group during the second quarter worth approximately $31,000. Cloud Capital Management LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $32,000. Finally, Riggs Asset Managment Co. Inc. lifted its position in UnitedHealth Group by 69.4% in the second quarter. Riggs Asset Managment Co. Inc. now owns 105 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $292.20 on Friday. The company has a market cap of $264.69 billion, a PE ratio of 22.15, a P/E/G ratio of 1.75 and a beta of 0.42. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. The firm’s 50 day moving average price is $331.39 and its 200-day moving average price is $323.38.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.09 by $0.02. The business had revenue of $113.22 billion for the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the firm earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.0%. UnitedHealth Group’s payout ratio is presently 67.02%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several analyst reports. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Piper Sandler restated an “overweight” rating on shares of UnitedHealth Group in a research report on Tuesday. Leerink Partners dropped their price objective on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a report on Wednesday. The Goldman Sachs Group began coverage on UnitedHealth Group in a research report on Tuesday, October 14th. They set a “buy” rating and a $406.00 target price for the company. Finally, Jefferies Financial Group reduced their price target on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research note on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $380.67.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Market and analyst support — Several firms kept buy/overweight ratings or reiterated long-term confidence after the Q4 release, arguing the sell-off may be overdone and highlighting UnitedHealth’s underlying margin initiatives and long-term fundamentals. UnitedHealth Q4 Earnings Review: The Selloff Looks Overdone After Results
• Positive Sentiment: Short-term rebound in ETFs — Healthcare ETFs and related funds moved as UNH bounced (~4% at one point) on a mixed Q4 print plus commentary that 2026 cost trends could improve, which likely supported intraday buying from funds and momentum traders. Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results
• Neutral Sentiment: Modest analyst target tweaks — Morgan Stanley trimmed its price target slightly to $409 but kept an Overweight rating, signaling stabilized expectations rather than a wholesale shift in conviction. This is a modest signal versus outright downgrades. UnitedHealth (UNH) Sees Modest Target Cut at Morgan Stanley as Outlook Stabilizes
• Negative Sentiment: Large put-option activity — Unusually high put buying (376,697 contracts, +131% vs. typical volume) indicates elevated downside hedging or speculative bearish positioning, increasing near-term downside pressure on the stock.
• Negative Sentiment: Analyst price-target cuts — Multiple firms reduced targets (examples: Jefferies to $340, Leerink to $345, Oppenheimer to $385, RBC to $361, UBS trimmed targets), which amplifies pessimism around near-term earnings/guidance and contributes to downward momentum.
• Negative Sentiment: Guidance & Medicare payment shock — The main catalyst for the rout was a cautious FY2026 outlook and disappointing Medicare Advantage payment updates; investors marked the company down sharply on lower-than-expected forward cash/earnings visibility. UnitedHealth (UNH) Loses 19.6% on Weak Outlook, Medicare Payment Update
• Negative Sentiment: Political stock sales & market-cap hit — Reports of politicians selling UNH before the crash and headlines about a $50–99 billion market-cap loss have heightened scrutiny and negative sentiment, which can prolong volatility. These 3 U.S. politicians suspiciously dumped UnitedHealth stock weeks before crash
• Negative Sentiment: Bearish commentary and “trap” warnings — Multiple op-eds and analyst notes argue the recovery may take time or that buying the dip could be a trap; that negative narrative is pressuring demand for the stock in the near term. UnitedHealth: Buying The Dip Could Be A Trap

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.